High-intensity chemotherapy versus palliative chemotherapy in patients over 60 years with acute myeloid leukemia

The use of high-intensity chemotherapy (HIC) for acute myeloid leukemia (AML) in the elderly is controversial. In the present study, it was assessed complete remission and overall survival of AML patients over 60 years treated with HIC or palliative chemotherapy. Patients with ECOG ≤ 2 and adequate...

Full description

Saved in:

Bibliographic Details
Published in:	Revista médica (Mexico : 1983) Vol. 54 Suppl 2; p. S148
Main Authors:	Medrano-Contreras, Jesús, Talavera-Piña, Juan Osvaldo, Guerrero-Rivera, Susana, Gutiérrez-Espíndola, Guillermo Rodolfo, Gómez-Cortés, Cynthia, Pérez-Rocha, Juan Fernando, Terreros-Muñoz, Eduardo, Meillón-García, Luis Antonio
Format:	Journal Article
Language:	Spanish
Published:	Mexico 2016
Subjects:	Aged Aged, 80 and over Anthracyclines - therapeutic use Antineoplastic Agents - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cytarabine - therapeutic use Dose-Response Relationship, Drug Drug Administration Schedule Female Humans Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - mortality Male Middle Aged Palliative Care - methods Retrospective Studies Treatment Outcome Chemotherapy Acute myeloid leukemia Elderly
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!